MedPath

DOPRAM INJECTABLE LIQ 20MG/ML

DOPRAM INJECTABLE LIQ 20MG/ML

Discontinued
DIN Number

02041839

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

wyeth-ayerst canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02041839
AIG Number0101477001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R07AB01 DOXAPRAM
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification28:20.32
Health Canada Classification

ACTIVE INGREDIENTS (1)

DOXAPRAM HYDROCHLORIDEActive
Strength: 20 MG / ML
Monograph: DOXAPRAM HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.